[HTML][HTML] Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - nature.com
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects,,–. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects,,–. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2.
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - europepmc.org
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - econpapers.repec.org
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects1–4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects1–4. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects 1-4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects 1-4. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - ideas.repec.org
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects1–4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects1–4. For clinical doses of metformin, AMP-activated protein …
[HTML][HTML] Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - ncbi.nlm.nih.gov
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Metformin, the most prescribed antidiabetic
medicine, has shown other benefits such as anti-ageing and anticancer effects< jats: sup> 1 …
medicine, has shown other benefits such as anti-ageing and anticancer effects< jats: sup> 1 …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - paper.sciencenet.cn
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects1, 2, 3, 4. For clinical doses of metformin, AMP-activated …
ageing and anticancer effects1, 2, 3, 4. For clinical doses of metformin, AMP-activated …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - …, 2022 - ui.adsabs.harvard.edu
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects 1-4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects 1-4. For clinical doses of metformin, AMP-activated protein …
Low-dose metformin targets the lysosomal AMPK pathway through PEN2.
T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu… - Nature, 2022 - europepmc.org
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …
ageing and anticancer effects 1–4. For clinical doses of metformin, AMP-activated protein …